Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-11 Purchase | 2023-01-13 6:20 pm | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 124,679 | $5.5995 | $698,138 | 282,770 (Direct) | View |
| 2022-06-03 Sale | 2022-06-06 4:49 pm | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 1,364 | $22.79 | $31,086 | 158,091 (Direct) | View |
| 2022-03-10 Sale | 2022-03-11 4:58 pm | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $35.02 | $1,105,200 | 159,455 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-21 4:20 pm | N/A 2034-06-19 | Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 4:27 pm | N/A 2034-06-07 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:05 pm | N/A 2033-06-06 | Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 4:11 pm | N/A 2033-06-06 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-01-19 Exercise | 2023-01-20 4:14 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 28,461 | $1.37 | 311,231 (Direct) | View |
| 2023-01-19 Exercise | 2023-01-20 4:14 pm | N/A 2023-02-06 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 28,461 | $0 | 311,231 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:42 pm | N/A 2032-06-09 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 20,543 | $0 | 178,634 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 4:10 pm | N/A 2032-06-07 | Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director | 18,118 | $0 | 18,118 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 4:58 pm | N/A 2022-03-12 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $0 | 159,455 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-11 4:58 pm | N/A N/A | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 31,562 | $1.63 | 159,455 (Direct) | View |
Ownership | 2021-07-29 9:04 pm | N/A 2030-01-25 | Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director | 0 | $0 | 221,360 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:24 pm | N/A 2031-06-01 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 7,015 | $0 | 163,789 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-05 4:17 pm | N/A 2030-05-01 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |